Luciano Latini

1.6k total citations
25 papers, 261 citations indexed

About

Luciano Latini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Luciano Latini has authored 25 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Luciano Latini's work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Advanced Breast Cancer Therapies (3 papers). Luciano Latini is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Advanced Breast Cancer Therapies (3 papers). Luciano Latini collaborates with scholars based in Italy, United States and France. Luciano Latini's co-authors include R. Cellerino, Rodolfo Mattioli, P. Lippe, Lucio Giustini, Mauro Finicelli, Alfredo Santinelli, Tiziana Squillaro, Antonio Giordano, Francesco Graziano and Barbara Pistilli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Luciano Latini

24 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luciano Latini Italy	9	111	105	91	43	41	25	261
Myoung Won Son South Korea	10	101 0.9×	68 0.6×	101 1.1×	32 0.7×	54 1.3×	35	261
Helen Bolanaki Greece	8	114 1.0×	138 1.3×	77 0.8×	53 1.2×	120 2.9×	20	301
Tatsuhiro Ishii Japan	11	116 1.0×	107 1.0×	84 0.9×	90 2.1×	40 1.0×	21	316
Cristiano Lanza Italy	10	126 1.1×	58 0.6×	87 1.0×	32 0.7×	69 1.7×	18	282
Viera Bajčiová Czechia	9	74 0.7×	106 1.0×	47 0.5×	30 0.7×	46 1.1×	34	294
Bogumiła Ciseł Poland	9	80 0.7×	52 0.5×	111 1.2×	40 0.9×	32 0.8×	17	267
C. Zingaretti Italy	3	187 1.7×	59 0.6×	139 1.5×	28 0.7×	38 0.9×	6	351
Shiaowen David Hsu United States	10	181 1.6×	102 1.0×	122 1.3×	46 1.1×	46 1.1×	37	313
Gökçe Aşkan United States	10	193 1.7×	64 0.6×	105 1.2×	39 0.9×	68 1.7×	18	356
Yi-Hong Ling China	10	123 1.1×	87 0.8×	120 1.3×	59 1.4×	62 1.5×	12	333

Countries citing papers authored by Luciano Latini

Since Specialization

Citations

This map shows the geographic impact of Luciano Latini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luciano Latini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luciano Latini more than expected).

Fields of papers citing papers by Luciano Latini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luciano Latini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luciano Latini. The network helps show where Luciano Latini may publish in the future.

Co-authorship network of co-authors of Luciano Latini

This figure shows the co-authorship network connecting the top 25 collaborators of Luciano Latini. A scholar is included among the top collaborators of Luciano Latini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luciano Latini. Luciano Latini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tedeschi, Roberto, et al.. (2025). Innovative knee ligament recovery: ultrasound-guided peptide injections for grade II medial collateral ligament tears. Minerva Orthopedics. 76(2).

Latini, Luciano, et al.. (2024). Clinical Efficacy and Safety of Ultrasound-Guided Injection with Low-Molecular-Weight Peptides from Hydrolyzed Collagen in Patients with Partial Supraspinatus Tendon Tears: A Pilot Study. Life. 14(11). 1351–1351. 3 indexed citations

Cortesi, Enrico, Federico Cappuzzo, Luca Galli, et al.. (2017). Treatment beyond progression in patients with advanced RCC participating in the expanded access programme (EAP). Annals of Oncology. 28. v316–v316. 4 indexed citations

Sobrero, Alberto, Luciano Latini, C. Barone, et al.. (2015). Review of RAISE, a Randomized, Double-Blind, Multicenter Phase III Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (RAM) or Placebo (PBO) in Patients (pts) With Metastatic Colorectal Carcinoma (mCRC) Progressive During or Following First-Line Combination Therapy With Bevacizumab (bev), Oxaliplatin (ox), and a Fluoropyrimidine (fp): Primary Results and Subgroup Analysis by KRAS Status. Annals of Oncology. 26. vi37–vi37. 1 indexed citations

Cutsem, Eric Van, Hans Prenen, Geert D’Haens, et al.. (2015). A phase I/II, open-label, randomised study of nintedanib plus mFOLFOX6 versus bevacizumab plus mFOLFOX6 in first-line metastatic colorectal cancer patients. Annals of Oncology. 26(10). 2085–2091. 35 indexed citations

Finicelli, Mauro, Giovanni Benedetti, Tiziana Squillaro, et al.. (2014). Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence. Oncotarget. 5(20). 9678–9688. 38 indexed citations

André, Fabrice, Patrick Neven, Antonino Musolino, et al.. (2013). Abstract OT2-6-04: Dovitinib, a receptor tyrosine kinase inhibitor in combination with fulvestrant in postmenopausal endocrine resistant human epidermal growth factor receptor 2 negative (HER2-) / hormone receptor-positive (HR+) breast cancer: A phase II, randomized, double blind, placebo-controlled study. Cancer Research. 73(24_Supplement). OT2–6. 2 indexed citations

Arena, Francis P., Shinzaburo Noguchi, Kathleen I. Pritchard, et al.. (2012). Everolimus for postmenopausal women with advanced breast cancer: Updated results of the BOLERO-2 phase III trial.. Journal of Clinical Oncology. 30(27_suppl). 99–99. 13 indexed citations

Pressiani, Tiziana, Lorenza Rimassa, C. Boni, et al.. (2011). Phase II randomized trial on dose-escalated sorafenib (S) versus best supportive care (BSC) in patients with advanced hepatocellular carcinoma (HCC) with disease progression on prior S treatment.. Journal of Clinical Oncology. 29(15_suppl). 4115–4115. 8 indexed citations

10.

Barocci, Simone, et al.. (2010). HB&L System: rapid determination of antibiotic sensitivity of bacteria isolated from blood cultures.. Microbiologia medica. 25(1). 2 indexed citations

11.

Doni, Laura, Alessandra Perin, Luigi Manzione, et al.. (2010). The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy. Critical Reviews in Oncology/Hematology. 77(1). 70–77. 8 indexed citations

12.

Pivot, Xavier, S. Verma, Christoph Thomssen, et al.. (2009). Clinical benefit of bevacizumab (BV) plus first-line docetaxel (D) in elderly patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC): AVADO study. Journal of Clinical Oncology. 27(15_suppl). 1094–1094. 16 indexed citations

13.

Braconi, Chiara, R. Bracci, Italo Bearzi, et al.. (2008). KIT and PDGFRα mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study. Annals of Oncology. 19(4). 706–710. 27 indexed citations

14.

Ruzzo, Annamaria, Emanuele Canestrari, Paolo Enrico Maltese, et al.. (2007). Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer. Clinical Chemistry and Laboratory Medicine (CCLM). 45(7). 822–8. 56 indexed citations

15.

Mastro, Lucia Del, Matteo Clavarezza, D. Amadori, et al.. (2007). Once-weekly epoetin beta treatment in anemic patients with breast cancer receiving chemotherapy: Interim analysis of a multicenter, single arm study. Journal of Clinical Oncology. 25(18_suppl). 19605–19605. 1 indexed citations

16.

Lippe, P., Rossana Berardi, Cristian Massacesi, et al.. (2002). Desmoplastic Small Round Cell Tumour: A Description of Two Cases and Review of the Literature. Oncology. 64(1). 14–17. 16 indexed citations

17.

Piga, A., Stefano Cascinu, Luciano Latini, et al.. (1996). A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer. British Journal of Cancer. 74(6). 971–974. 7 indexed citations

18.

Cascinu, Stefano, Luciano Latini, Anna Fedeli, et al.. (1996). The clinical impact of FEM regimen (5-fluorouracil, 4-epidoxorubicin and mitomycin-C) in advanced gastric cancer patients.. PubMed. 15(6B). 2781–3. 3 indexed citations

19.

Graziano, Francesco, R. Cellerino, Fabio Menestrina, et al.. (1995). Synchronous Primary Hepatic Lymphoma and Epidermoid Lung Carcinoma Treated with Chemotherapy and Surgery. American Journal of Clinical Oncology. 18(3). 194–198. 7 indexed citations

20.

Ganeshaguru, K., A. Piga, Luciano Latini, & A. V. Hoffbrand. (1989). Inability of Poly-ADP-Ribosylation Inhibitors to Protect Peripheral Blood Lymphocytes from the Toxic Effects of ADA Inhibition. Advances in experimental medicine and biology. 253B. 251–258. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact